Brind.

FibroBiologics, Inc., based in Houston, is scheduled to present at a conference in New York City.

1 report, 1 independent Updated Aug 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

FibroBiologics, Inc., based in Houston, is scheduled to present at a conference in New York City.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Charles River Laboratories secured a contract to produce FibroBiologics' CYWC628 product as a Contract Development and Manufacturing Organization (CDMO).Sub-event
  2. FibroBiologics is based in Houston and presenting in NYC.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireFibroBiologics to Present at the H.C. Wainwright 27th Annual Global Investment Conference HOUSTON, Aug. 27, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical